GABAPENTIN ENACARBIL

GABAPENTIN ENACARBIL was reported 2844 times

GABAPENTIN ENACARBIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CULTURE WOUND 1 0.3333
1 INFANTILE BACK ARCHING 16 0.1702
2 RIB DEFORMITY 17 0.0669
3 COCCYGECTOMY 1 0.0625
4 ANTACID THERAPY 8 0.0615
5 SLEEP DISORDER THERAPY 12 0.0606
6 TONGUE SPASM 15 0.0479
7 CARTILAGE OPERATION 1 0.0476
8 ALCOHOLIC PSYCHOSIS 1 0.0476
9 BACTEROIDES INFECTION 11 0.0421
10 APPENDICOLITH 16 0.0413
11 ANALGESIC THERAPY 13 0.0405
12 DRUG THERAPY 13 0.0383
13 REVERSIBLE AIRWAYS OBSTRUCTION 18 0.0354
14 ANTICOAGULANT THERAPY 8 0.0282
15 CHRONIC INFLAMMATORY RESPONSE SYNDROME 1 0.0244
16 DEVICE LEAD DAMAGE 1 0.0208
17 PSYCHOGENIC PAIN DISORDER 2 0.0194
18 BLOOD PRESSURE ORTHOSTATIC ABNORMAL 3 0.0194
19 CHONDROPLASTY 1 0.0185
20 LARGE INTESTINE OPERATION 2 0.0122
21 NASAL OBSTRUCTION 18 0.0096
22 MALIGNANT MELANOMA STAGE 0 2 0.0096
23 MICROGRAPHIC SKIN SURGERY 2 0.0093
24 CONGENITAL HIATUS HERNIA 2 0.0088
25 BENIGN UTERINE NEOPLASM 1 0.0085
26 BILIARY NEOPLASM 1 0.0081
27 BONE LESION EXCISION 1 0.0066
28 CHONDROSARCOMA 1 0.0063
29 ANION GAP 4 0.0063
30 BLOOD PHOSPHORUS INCREASED 16 0.0059
31 ASTHMA EXERCISE INDUCED 2 0.0057
32 SMALL CELL LUNG CANCER METASTATIC 2 0.0057
33 MYOFASCIAL PAIN SYNDROME 4 0.0056
34 CHEST X-RAY ABNORMAL 17 0.0055
35 ANTIPHOSPHOLIPID ANTIBODIES 1 0.0051
36 HYPERPHOSPHATAEMIA 11 0.0051
37 ADRENOMEGALY 1 0.0048
38 THROAT CLEARING 18 0.0048
39 VULVOVAGINAL RASH 2 0.0045
40 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 1 0.0043
41 BLEPHARAL PIGMENTATION 2 0.0040
42 PRE-EXISTING CONDITION IMPROVED 23 0.0037
43 TOXICITY TO VARIOUS AGENTS 594 0.0035
44 BURNS FIRST DEGREE 1 0.0035
45 TONGUE MOVEMENT DISTURBANCE 3 0.0035
46 COMPLETED SUICIDE 277 0.0033
47 DEFIANT BEHAVIOUR 1 0.0032
48 BED REST 1 0.0032
49 STAPHYLOCOCCAL ABSCESS 2 0.0031
50 RESTLESS LEGS SYNDROME 56 0.0031
51 FULL BLOOD COUNT ABNORMAL 32 0.0030
52 SARS-COV-2 TEST NEGATIVE 2 0.0030
53 SCLERAL HYPERAEMIA 2 0.0029
54 FEELING OF RELAXATION 2 0.0029
55 IRON DEFICIENCY 13 0.0029
56 AORTIC STENOSIS 10 0.0029
57 CERVICAL RADICULOPATHY 2 0.0028
58 PARASOMNIA 2 0.0028
59 CHRONIC LEFT VENTRICULAR FAILURE 1 0.0028
60 BLOOD URIC ACID INCREASED 16 0.0028
61 MYOCLONUS 33 0.0028
62 INFUSION SITE MASS 3 0.0028
63 ABSCESS BACTERIAL 1 0.0028
64 CARDIO-RESPIRATORY ARREST 110 0.0026
65 BREATH HOLDING 1 0.0026
66 TOE OPERATION 2 0.0025
67 DEATH OF RELATIVE 1 0.0025
68 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 12 0.0024
69 EYE MOVEMENT DISORDER 16 0.0023
70 BELLIGERENCE 1 0.0023
71 ACTINIC KERATOSIS 6 0.0023
72 THALAMUS HAEMORRHAGE 2 0.0023
73 RHINITIS 18 0.0022
74 ANASTOMOTIC ULCER 1 0.0022
75 PRODUCT APPEARANCE CONFUSION 2 0.0022
76 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 2 0.0022
77 EATING DISORDER SYMPTOM 1 0.0022
78 TUNNEL VISION 4 0.0021
79 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
80 UPPER-AIRWAY COUGH SYNDROME 17 0.0021
81 ATROPHY 4 0.0021
82 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 34 0.0020
83 MYASTHENIA GRAVIS 16 0.0020
84 BREAST CONSERVING SURGERY 1 0.0020
85 PHYSICAL DECONDITIONING 5 0.0019
86 OPHTHALMOPLEGIA 3 0.0019
87 SLEEP TERROR 8 0.0019
88 COATING IN MOUTH 1 0.0019
89 SOMATIC SYMPTOM DISORDER 2 0.0019
90 ACCIDENTAL OVERDOSE 67 0.0018
91 APPENDICITIS 17 0.0018
92 MIDDLE EAR EFFUSION 4 0.0018
93 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 4 0.0018
94 BURNING MOUTH SYNDROME 1 0.0018
95 DISTRIBUTIVE SHOCK 4 0.0018
96 MOANING 2 0.0018
97 CHOREA 3 0.0017
98 SERUM FERRITIN DECREASED 3 0.0017
99 BREAKTHROUGH PAIN 4 0.0017
100 EPIDIDYMITIS 2 0.0017
101 PATELLA FRACTURE 4 0.0017
102 HANGOVER 6 0.0017
103 DEVICE MAINTENANCE ISSUE 1 0.0017
104 SPUTUM DISCOLOURED 16 0.0017
105 DRUG ABUSE 138 0.0017
106 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS 3 0.0016
107 FRACTURED COCCYX 2 0.0016
108 CELLULITIS STAPHYLOCOCCAL 1 0.0015
109 ABNORMAL SLEEP-RELATED EVENT 2 0.0015
110 DRUG MONITORING PROCEDURE INCORRECTLY PERFORMED 1 0.0015
111 HYPOPHOSPHATAEMIA 11 0.0015
112 CHOREOATHETOSIS 1 0.0015
113 INFUSION SITE RASH 2 0.0015
114 NEURALGIA 35 0.0014
115 DRUG WITHDRAWAL SYNDROME NEONATAL 21 0.0014
116 CATAPLEXY 2 0.0014
117 BLOOD FOLATE DECREASED 1 0.0014
118 IMMOBILE 6 0.0014
119 SOMNAMBULISM 9 0.0014
120 DRUG-DISEASE INTERACTION 1 0.0014
121 VENTRICULAR FIBRILLATION 15 0.0013
122 FEELING DRUNK 10 0.0013
123 BASOPHIL COUNT INCREASED 1 0.0013
124 SENSORY DISTURBANCE 21 0.0013
125 INFUSION SITE PRURITUS 4 0.0013
126 INAPPROPRIATE AFFECT 2 0.0013
127 DEVICE DAMAGE 1 0.0013
128 COLON CANCER METASTATIC 2 0.0012
129 IMPAIRED DRIVING ABILITY 14 0.0012
130 ACNE PUSTULAR 1 0.0012
131 DEVELOPMENTAL HIP DYSPLASIA 1 0.0012
132 ANXIETY DISORDER 4 0.0012
133 ALLERGIC SINUSITIS 1 0.0012
134 DRUG TITRATION ERROR 3 0.0012
135 LUNG OPACITY 3 0.0011
136 RADICULOPATHY 3 0.0011
137 DRUG DETOXIFICATION 1 0.0011
138 TROPONIN INCREASED 8 0.0011
139 CARDIOGENIC SHOCK 15 0.0010
140 VULVOVAGINAL MYCOTIC INFECTION 4 0.0010
141 DEVICE RELATED THROMBOSIS 1 0.0010
142 DIPLEGIA 2 0.0010
143 REBOUND ACID HYPERSECRETION 3 0.0010
144 BREAST DISCOMFORT 1 0.0010
145 BREAST NEOPLASM 1 0.0010
146 ALVEOLITIS ALLERGIC 1 0.0010
147 PRODUCT ODOUR ABNORMAL 10 0.0010
148 BURNS THIRD DEGREE 1 0.0009
149 NEUROGENIC BLADDER 2 0.0009
150 SLEEP DEFICIT 2 0.0009
151 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
152 STUPOR 3 0.0009
153 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
154 HYPERLIPIDAEMIA 11 0.0009
155 LYMPHOCYTE COUNT INCREASED 3 0.0009
156 BACTERIAL INFECTION 17 0.0009
157 COMPLEX PARTIAL SEIZURES 1 0.0009
158 DEMENTIA WITH LEWY BODIES 1 0.0009
159 CARDIAC HYPERTROPHY 1 0.0009
160 POTENTIATING DRUG INTERACTION 3 0.0009
161 LICHENOID KERATOSIS 2 0.0009
162 EYELID DISORDER 2 0.0009
163 AORTIC THROMBOSIS 1 0.0009
164 HAEMANGIOMA 2 0.0009
165 SOCIAL AVOIDANT BEHAVIOUR 5 0.0009
166 NECK SURGERY 2 0.0009
167 BLADDER OPERATION 1 0.0009
168 LOGORRHOEA 3 0.0009
169 THERAPEUTIC RESPONSE UNEXPECTED 38 0.0008
170 ACUTE LUNG INJURY 1 0.0008
171 FACIAL BONES FRACTURE 3 0.0008
172 INTENTIONAL UNDERDOSE 6 0.0008
173 RETINAL TEAR 2 0.0008
174 DEVICE INFUSION ISSUE 2 0.0008
175 VENTRICULAR HYPERTROPHY 2 0.0008
176 SEDATION COMPLICATION 2 0.0008
177 INITIAL INSOMNIA 8 0.0008
178 MEAN CELL VOLUME INCREASED 2 0.0008
179 PRODUCT COLOUR ISSUE 4 0.0008
180 ADJUSTMENT DISORDER 1 0.0008
181 POLYP 5 0.0008
182 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
183 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
184 TRIGEMINAL NEURALGIA 3 0.0007
185 BREAST MASS 5 0.0007
186 ENURESIS 3 0.0007
187 BRADYPNOEA 2 0.0007
188 ACCIDENTAL POISONING 1 0.0007
189 THERAPEUTIC RESPONSE DELAYED 2 0.0007
190 DYSKINESIA 29 0.0007
191 BLADDER DISORDER 7 0.0007
192 RESPIRATORY SYMPTOM 2 0.0007
193 INTERVERTEBRAL DISC DISORDER 3 0.0007
194 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 12 0.0007
195 TEARFULNESS 3 0.0007
196 LUNG CANCER METASTATIC 2 0.0007
197 ULCER 11 0.0007
198 FINE MOTOR SKILL DYSFUNCTION 2 0.0007
199 MAJOR DEPRESSION 5 0.0007
200 SLEEP APNOEA SYNDROME 13 0.0007
201 URINE ODOUR ABNORMAL 4 0.0007
202 DARK CIRCLES UNDER EYES 1 0.0007
203 COMPLEX REGIONAL PAIN SYNDROME 1 0.0007
204 METABOLIC ENCEPHALOPATHY 2 0.0007
205 RESPIRATORY DEPRESSION 8 0.0007
206 EYE OPERATION 3 0.0007
207 SEDATION 17 0.0006
208 NEPHROGENIC ANAEMIA 3 0.0006
209 CONCUSSION 5 0.0006
210 BRONCHIAL DISORDER 1 0.0006
211 BACTERIAL VAGINOSIS 1 0.0006
212 DYSPNOEA EXERTIONAL 24 0.0006
213 SEASONAL ALLERGY 9 0.0006
214 THERAPEUTIC RESPONSE SHORTENED 21 0.0006
215 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 33 0.0006
216 CYSTITIS INTERSTITIAL 1 0.0006
217 SOMNOLENCE 125 0.0006
218 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
219 GOUT 11 0.0006
220 INFUSION SITE HAEMORRHAGE 2 0.0006
221 LYME DISEASE 2 0.0006
222 BILIARY DYSKINESIA 1 0.0006
223 PETIT MAL EPILEPSY 3 0.0006
224 FACIAL PARALYSIS 5 0.0006
225 BLOOD PH DECREASED 1 0.0006
226 REGURGITATION 2 0.0006
227 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
228 CERVICAL SPINAL STENOSIS 1 0.0006
229 JOINT EFFUSION 4 0.0006
230 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
231 TACHYPHRENIA 2 0.0006
232 FORMICATION 4 0.0006
233 BURNS SECOND DEGREE 1 0.0006
234 MUSCLE SPASTICITY 7 0.0006
235 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
236 SPINAL OPERATION 7 0.0006
237 NYSTAGMUS 3 0.0006
238 BREAST CYST 1 0.0006
239 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
240 AORTIC VALVE STENOSIS 1 0.0006
241 DEVICE ALARM ISSUE 1 0.0006
242 MONOCYTE COUNT INCREASED 2 0.0006
243 END STAGE RENAL DISEASE 10 0.0005
244 CONDUCTION DISORDER 1 0.0005
245 DEAFNESS UNILATERAL 3 0.0005
246 ASCITES 16 0.0005
247 HYPOMANIA 2 0.0005
248 WHEEZING 32 0.0005
249 DIFFUSE ALOPECIA 1 0.0005
250 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 38 0.0005
251 BLADDER SPASM 1 0.0005
252 MULTIPLE ORGAN DYSFUNCTION SYNDROME 15 0.0005
253 SNORING 2 0.0005
254 AFFECT LABILITY 5 0.0005
255 ARTERIAL THROMBOSIS 1 0.0005
256 ALCOHOL INTERACTION 1 0.0005
257 SLEEP DISORDER 36 0.0005
258 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
259 ENERGY INCREASED 3 0.0005
260 INABILITY TO AFFORD MEDICATION 5 0.0005
261 INTENTIONAL PRODUCT MISUSE 44 0.0005
262 FUNGAL SKIN INFECTION 2 0.0005
263 VITAMIN B12 DEFICIENCY 2 0.0005
264 SPINAL FUSION SURGERY 2 0.0005
265 PERIPHERAL VENOUS DISEASE 2 0.0005
266 CARDIOMEGALY 6 0.0005
267 SPINAL STENOSIS 2 0.0005
268 SCOLIOSIS 3 0.0005
269 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
270 MIDDLE INSOMNIA 9 0.0005
271 EAR SWELLING 1 0.0005
272 MUSCLE FATIGUE 2 0.0005
273 TONGUE DISCOMFORT 2 0.0005
274 ABNORMAL DREAMS 13 0.0005
275 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
276 ALCOHOLISM 2 0.0005
277 HEREDITARY ANGIOEDEMA 5 0.0005
278 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
279 HYSTERECTOMY 4 0.0005
280 CHAPPED LIPS 2 0.0005
281 PRODUCT PRESCRIBING ISSUE 10 0.0005
282 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
283 BEDRIDDEN 6 0.0005
284 CORNEAL DISORDER 1 0.0005
285 ACTIVITIES OF DAILY LIVING IMPAIRED 9 0.0005
286 COLONOSCOPY 1 0.0005
287 CATHETERISATION CARDIAC 2 0.0005
288 CHOLESTATIC LIVER INJURY 1 0.0004
289 MYOSITIS 4 0.0004
290 BRONCHIECTASIS 3 0.0004
291 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
292 LIMB INJURY 12 0.0004
293 PRODUCTIVE COUGH 21 0.0004
294 ABDOMINAL HERNIA 2 0.0004
295 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
296 INSOMNIA 116 0.0004
297 RESPIRATION ABNORMAL 3 0.0004
298 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
299 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1 0.0004
300 SINUSITIS 44 0.0004
301 FEELING OF DESPAIR 2 0.0004
302 DISTURBANCE IN ATTENTION 23 0.0004
303 ARTERIOSCLEROSIS 4 0.0004
304 DRUG INTOLERANCE 41 0.0004
305 NEUROPATHY PERIPHERAL 40 0.0004
306 PRODUCT SUPPLY ISSUE 3 0.0004
307 FEELING JITTERY 8 0.0004
308 ENDOMETRIOSIS 2 0.0004
309 DRY MOUTH 34 0.0004
310 POOR QUALITY SLEEP 9 0.0004
311 LIMB OPERATION 2 0.0004
312 ASTHMA 47 0.0004
313 PANIC REACTION 3 0.0004
314 PHARYNGEAL SWELLING 4 0.0004
315 LUNG DISORDER 20 0.0004
316 WITHDRAWAL SYNDROME 17 0.0004
317 NIGHTMARE 14 0.0004
318 ACUTE PSYCHOSIS 1 0.0004
319 FOOT OPERATION 2 0.0004
320 INJECTION SITE INFLAMMATION 2 0.0004
321 FLUID INTAKE REDUCED 2 0.0004
322 CATHETER SITE HAEMORRHAGE 1 0.0004
323 DYSARTHRIA 15 0.0004
324 FEELING ABNORMAL 95 0.0004
325 VULVOVAGINAL PRURITUS 2 0.0004
326 TOXIC ENCEPHALOPATHY 2 0.0004
327 APPENDICITIS PERFORATED 1 0.0004
328 DYSPHONIA 23 0.0004
329 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 2 0.0004
330 AORTIC ARTERIOSCLEROSIS 1 0.0004
331 BLOOD CHLORIDE DECREASED 1 0.0004
332 LIMB DISCOMFORT 12 0.0004
333 HIATUS HERNIA 5 0.0004
334 BLOOD CHOLESTEROL INCREASED 18 0.0004
335 HYPERSOMNIA 11 0.0004
336 MALABSORPTION 2 0.0004
337 ARTERIAL OCCLUSIVE DISEASE 3 0.0004
338 GASTROOESOPHAGEAL REFLUX DISEASE 30 0.0004
339 STENT PLACEMENT 3 0.0004
340 MENTAL IMPAIRMENT 9 0.0004
341 BRUXISM 2 0.0004
342 CHONDROPATHY 1 0.0004
343 IMPAIRED GASTRIC EMPTYING 5 0.0004
344 CLUMSINESS 1 0.0004
345 MANIA 6 0.0004
346 MENTAL STATUS CHANGES 10 0.0004
347 MEDICATION ERROR 20 0.0004
348 DIABETES MELLITUS 27 0.0004
349 SWELLING 33 0.0004
350 PRESCRIBED UNDERDOSE 7 0.0004
351 MOUTH SWELLING 2 0.0003
352 COMA SCALE ABNORMAL 1 0.0003
353 DYSSTASIA 10 0.0003
354 DECREASED INTEREST 2 0.0003
355 FACIAL PAIN 3 0.0003
356 INTENTIONAL DRUG MISUSE 7 0.0003
357 ATYPICAL PNEUMONIA 1 0.0003
358 CRANIOCEREBRAL INJURY 1 0.0003
359 BURSITIS 4 0.0003
360 SCHIZOPHRENIA 4 0.0003
361 BURNING SENSATION 23 0.0003
362 INSURANCE ISSUE 5 0.0003
363 MENISCUS INJURY 2 0.0003
364 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
365 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 2 0.0003
366 PRODUCT DISPENSING ERROR 7 0.0003
367 BLOOD CREATININE DECREASED 1 0.0003
368 NASAL DRYNESS 2 0.0003
369 HALLUCINATION 24 0.0003
370 FRACTURE 6 0.0003
371 SPINAL DISORDER 3 0.0003
372 DRUG EFFECT INCREASED 1 0.0003
373 IRRITABILITY 19 0.0003
374 SEROTONIN SYNDROME 6 0.0003
375 DYSTONIA 6 0.0003
376 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0003
377 AUTOIMMUNE DISORDER 3 0.0003
378 CHOKING 6 0.0003
379 PRODUCT USE IN UNAPPROVED INDICATION 76 0.0003
380 SUICIDAL IDEATION 28 0.0003
381 BREAST ENLARGEMENT 1 0.0003
382 URINARY INCONTINENCE 9 0.0003
383 HOSPICE CARE 3 0.0003
384 DYSGRAPHIA 2 0.0003
385 PULMONARY CONGESTION 4 0.0003
386 LIGAMENT SPRAIN 3 0.0003
387 GENERALISED TONIC-CLONIC SEIZURE 5 0.0003
388 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
389 BALANCE DISORDER 26 0.0003
390 RESTLESSNESS 11 0.0003
391 SKIN MASS 2 0.0003
392 PRODUCT PHYSICAL ISSUE 6 0.0003
393 PRODUCT LABEL ISSUE 2 0.0003
394 MOTOR DYSFUNCTION 3 0.0003
395 MUSCLE SPASMS 54 0.0003
396 EAR DISCOMFORT 3 0.0003
397 ECCHYMOSIS 2 0.0003
398 RIB FRACTURE 6 0.0003
399 PERIPHERAL COLDNESS 4 0.0003
400 CERVICAL VERTEBRAL FRACTURE 1 0.0003
401 LYMPHOEDEMA 2 0.0003
402 WEIGHT FLUCTUATION 3 0.0003
403 KNEE ARTHROPLASTY 6 0.0003
404 BLOOD TEST ABNORMAL 4 0.0003
405 INCONTINENCE 3 0.0003
406 DEPRESSIVE SYMPTOM 1 0.0003
407 CHEST DISCOMFORT 29 0.0003
408 DIVERTICULUM 2 0.0003
409 JOINT INJURY 6 0.0003
410 APPENDICECTOMY 1 0.0003
411 UNEVALUABLE EVENT 21 0.0003
412 BONE LESION 1 0.0003
413 AMNESIA 18 0.0003
414 BIPOLAR DISORDER 3 0.0003
415 CUTANEOUS VASCULITIS 1 0.0003
416 ASPIRATION 3 0.0003
417 BLOOD GLUCOSE FLUCTUATION 3 0.0003
418 MULTIPLE SCLEROSIS 13 0.0003
419 ALCOHOL USE 1 0.0003
420 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
421 LIP SWELLING 9 0.0003
422 COLON CANCER 4 0.0003
423 THINKING ABNORMAL 5 0.0003
424 HYPONATRAEMIA 15 0.0003
425 PAROSMIA 2 0.0003
426 BLOOD COUNT ABNORMAL 4 0.0003
427 MYOCARDIAL ISCHAEMIA 3 0.0003
428 ILL-DEFINED DISORDER 16 0.0003
429 CHOLECYSTECTOMY 3 0.0003
430 COMMUNICATION DISORDER 1 0.0003
431 CLAVICLE FRACTURE 1 0.0003
432 THYROID DISORDER 4 0.0003
433 ANKLE FRACTURE 4 0.0003
434 COGNITIVE DISORDER 12 0.0003
435 APNOEA 2 0.0003
436 PELVIC FRACTURE 2 0.0003
437 MOOD ALTERED 7 0.0003
438 HAEMORRHAGIC STROKE 2 0.0003
439 SPINAL PAIN 3 0.0003
440 PRODUCT USE COMPLAINT 4 0.0003
441 DISABILITY 5 0.0003
442 HEAD INJURY 8 0.0003
443 DIZZINESS 126 0.0003
444 DISORIENTATION 10 0.0003
445 GINGIVAL PAIN 2 0.0003
446 ACCIDENT 3 0.0003
447 MACULAR DEGENERATION 3 0.0003
448 SEIZURE 29 0.0003
449 ATRIAL FLUTTER 2 0.0003
450 WRIST FRACTURE 3 0.0003
451 ADVERSE EVENT 23 0.0002
452 TACHYCARDIA 22 0.0002
453 MUSCLE TIGHTNESS 4 0.0002
454 APPLICATION SITE DISCOLOURATION 1 0.0002
455 ENCEPHALOPATHY 6 0.0002
456 HYPERAESTHESIA 2 0.0002
457 EYE DISORDER 8 0.0002
458 APPLICATION SITE EXFOLIATION 1 0.0002
459 MENSTRUAL DISORDER 2 0.0002
460 ILEUS 3 0.0002
461 PERIPHERAL SWELLING 37 0.0002
462 INJECTION SITE DISCOLOURATION 3 0.0002
463 COAGULOPATHY 4 0.0002
464 URINARY RETENTION 8 0.0002
465 OEDEMA 13 0.0002
466 DRUG INTERACTION 38 0.0002
467 ABDOMINAL DISTENSION 25 0.0002
468 SURGERY 14 0.0002
469 ANGER 8 0.0002
470 CARDIAC FAILURE CONGESTIVE 19 0.0002
471 PARAESTHESIA 37 0.0002
472 AORTIC VALVE INCOMPETENCE 1 0.0002
473 VITAMIN D DECREASED 2 0.0002
474 THERAPY CESSATION 12 0.0002
475 MULTIPLE SCLEROSIS RELAPSE 16 0.0002
476 VISION BLURRED 32 0.0002
477 FALL 77 0.0002
478 COMA 11 0.0002
479 PYELONEPHRITIS 2 0.0002
480 DELIRIUM 8 0.0002
481 DEPRESSION 52 0.0002
482 DRUG ADMINISTRATION ERROR 7 0.0002
483 DYSPHEMIA 1 0.0002
484 DEPRESSED LEVEL OF CONSCIOUSNESS 9 0.0002
485 COLD SWEAT 4 0.0002
486 IMMUNOSUPPRESSION 2 0.0002
487 PRODUCT COMMUNICATION ISSUE 2 0.0002
488 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
489 LYMPHOCYTE COUNT DECREASED 4 0.0002
490 HEAD DISCOMFORT 4 0.0002
491 CONSTIPATION 49 0.0002
492 GAIT DISTURBANCE 43 0.0002
493 SWOLLEN TONGUE 7 0.0002
494 THROMBOSIS 18 0.0002
495 CONDITION AGGRAVATED 68 0.0002
496 QUALITY OF LIFE DECREASED 3 0.0002
497 MOBILITY DECREASED 16 0.0002
498 PRODUCT TASTE ABNORMAL 3 0.0002
499 OROPHARYNGEAL DISCOMFORT 2 0.0002
500 LEUKOCYTOSIS 4 0.0002
501 AKATHISIA 3 0.0002
502 PRODUCT AVAILABILITY ISSUE 5 0.0002
503 PANIC ATTACK 8 0.0002
504 CORONARY ARTERY OCCLUSION 3 0.0002
505 MEMORY IMPAIRMENT 30 0.0002
506 NEPHROLITHIASIS 10 0.0002
507 MOVEMENT DISORDER 7 0.0002
508 BRAIN NEOPLASM 2 0.0002
509 SKIN DISCOLOURATION 10 0.0002
510 NERVE COMPRESSION 2 0.0002
511 ORAL DISCOMFORT 3 0.0002
512 ARTHRITIS INFECTIVE 1 0.0002
513 HUNGER 3 0.0002
514 ROAD TRAFFIC ACCIDENT 9 0.0002
515 APHONIA 3 0.0002
516 OFF LABEL USE 187 0.0002
517 BLOOD SODIUM DECREASED 4 0.0002
518 CHRONIC LYMPHOCYTIC LEUKAEMIA 1 0.0002
519 FUNGAL INFECTION 7 0.0002
520 MIGRAINE 20 0.0002
521 INCREASED APPETITE 4 0.0002
522 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
523 LETHARGY 12 0.0002
524 CONTUSION 20 0.0002
525 HYPERCHOLESTEROLAEMIA 2 0.0002
526 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
527 DIZZINESS POSTURAL 2 0.0002
528 APATHY 3 0.0002
529 FIBROMYALGIA 5 0.0002
530 VITAMIN D DEFICIENCY 2 0.0002
531 HAEMORRHOIDS 4 0.0002
532 TREMOR 34 0.0002
533 RENAL TUBULAR NECROSIS 2 0.0002
534 KIDNEY INFECTION 4 0.0002
535 CARDIOMYOPATHY 3 0.0002
536 BREATH SOUNDS ABNORMAL 1 0.0002
537 MUSCULAR WEAKNESS 23 0.0002
538 RENAL INJURY 6 0.0002
539 DIABETIC NEUROPATHY 1 0.0002
540 WEIGHT INCREASED 45 0.0002
541 ANEURYSM 1 0.0002
542 UPPER LIMB FRACTURE 4 0.0002
543 PULMONARY EMBOLISM 19 0.0002
544 SALIVARY HYPERSECRETION 2 0.0002
545 PRODUCT DOSE OMISSION 13 0.0002
546 APHASIA 6 0.0002
547 LYMPHADENOPATHY 7 0.0002
548 DYSPHORIA 1 0.0002
549 EXTRA DOSE ADMINISTERED 8 0.0002
550 CHRONIC KIDNEY DISEASE 15 0.0002
551 VERTIGO 12 0.0002
552 SUBARACHNOID HAEMORRHAGE 2 0.0002
553 DRUG DISPENSING ERROR 3 0.0002
554 SLUGGISHNESS 2 0.0002
555 BLOOD PRESSURE DECREASED 13 0.0002
556 NEUTROPHIL COUNT INCREASED 2 0.0002
557 EUPHORIC MOOD 2 0.0002
558 EYE PAIN 11 0.0002
559 TEMPERATURE INTOLERANCE 2 0.0002
560 RASH GENERALISED 5 0.0002
561 CRYING 7 0.0002
562 BRAIN FOG 3 0.0002
563 DRUG-INDUCED LIVER INJURY 6 0.0002
564 AGITATION 14 0.0002
565 CATATONIA 1 0.0002
566 BLOOD LACTIC ACID INCREASED 1 0.0002
567 HALLUCINATION, VISUAL 4 0.0002
568 JOINT DISLOCATION 2 0.0002
569 HALLUCINATION, AUDITORY 3 0.0002
570 OBESITY 3 0.0002
571 MOOD SWINGS 6 0.0002
572 HYPOTHYROIDISM 6 0.0002
573 IMPAIRED WORK ABILITY 4 0.0002
574 COMPRESSION FRACTURE 1 0.0002
575 NIGHT SWEATS 6 0.0002
576 FEAR 5 0.0002
577 SKIN CANCER 4 0.0002
578 PRURITUS GENERALISED 4 0.0002
579 BEHAVIOUR DISORDER 1 0.0002
580 CHEILITIS 1 0.0002
581 ASTHENOPIA 1 0.0002
582 CYSTIC FIBROSIS 1 0.0002
583 DIVERTICULITIS 5 0.0002
584 HYPOAESTHESIA 27 0.0002
585 TOOTH DISORDER 4 0.0002
586 NERVE INJURY 2 0.0002
587 NECK PAIN 10 0.0002
588 DEMENTIA 5 0.0002
589 PULMONARY OEDEMA 8 0.0002
590 ORAL PAIN 4 0.0002
591 THERAPEUTIC PRODUCT EFFECT DECREASED 8 0.0002
592 OCULAR DISCOMFORT 2 0.0002
593 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 36 0.0002
594 STATUS EPILEPTICUS 2 0.0002
595 HEADACHE 110 0.0002
596 INTENTIONAL DOSE OMISSION 5 0.0002
597 DERMATITIS CONTACT 2 0.0002
598 MICTURITION URGENCY 2 0.0002
599 INTERNAL HAEMORRHAGE 2 0.0002
600 CARDIAC VALVE DISEASE 1 0.0002
601 MUSCULOSKELETAL DISCOMFORT 3 0.0002
602 PARANOIA 3 0.0002
603 MUSCLE TWITCHING 4 0.0002
604 UPPER RESPIRATORY TRACT INFECTION 8 0.0002
605 PAIN IN EXTREMITY 51 0.0002
606 NERVOUSNESS 9 0.0002
607 ANXIETY 49 0.0002
608 LOCAL SWELLING 3 0.0002
609 SPEECH DISORDER 9 0.0002
610 INTENTIONAL PRODUCT USE ISSUE 15 0.0002
611 HYPOXIA 6 0.0002
612 PRODUCT DOSE OMISSION ISSUE 50 0.0002
613 BRADYKINESIA 1 0.0002
614 NEUROLEPTIC MALIGNANT SYNDROME 2 0.0002
615 BLOOD IRON DECREASED 2 0.0002
616 ATAXIA 2 0.0002
617 GALLBLADDER DISORDER 3 0.0002
618 CATARACT 10 0.0002
619 RHABDOMYOLYSIS 7 0.0002
620 CARDIAC PACEMAKER INSERTION 1 0.0002
621 GASTROINTESTINAL DISORDER 15 0.0002
622 ADVERSE DRUG REACTION 15 0.0002
623 WRONG TECHNIQUE IN DRUG USAGE PROCESS 6 0.0002
624 SUICIDE ATTEMPT 10 0.0002
625 DRUG INEFFECTIVE 217 0.0002
626 NO THERAPEUTIC RESPONSE 2 0.0002
627 DRUG ABUSER 1 0.0002
628 BRONCHITIS 12 0.0002
629 TENDON RUPTURE 2 0.0002
630 DRUG DIVERSION 1 0.0002
631 GENERALISED OEDEMA 2 0.0002
632 CHOLANGITIS 1 0.0002
633 EYE SWELLING 6 0.0002
634 HEPATIC STEATOSIS 3 0.0002
635 TOOTH EXTRACTION 2 0.0002
636 BLISTER 9 0.0002
637 MUSCULOSKELETAL STIFFNESS 14 0.0002
638 PHOTOPHOBIA 3 0.0002
639 CELLULITIS 8 0.0002
640 URINARY TRACT INFECTION 27 0.0002
641 MUSCLE ATROPHY 2 0.0002
642 GASTRIC ULCER 3 0.0002
643 CYSTITIS 5 0.0002
644 HYPOPHAGIA 4 0.0002
645 METABOLIC ACIDOSIS 5 0.0002
646 HEPATITIS 4 0.0002
647 POST PROCEDURAL COMPLICATION 3 0.0002
648 MYDRIASIS 2 0.0002
649 DYSPNOEA 88 0.0002
650 INFUSION SITE PAIN 2 0.0002
651 URTICARIA 26 0.0002
652 PRESCRIBED OVERDOSE 3 0.0002
653 ABDOMINAL DISCOMFORT 26 0.0002
654 APPLICATION SITE VESICLES 1 0.0002
655 NAUSEA 122 0.0002
656 ORAL HERPES 3 0.0002
657 BRADYPHRENIA 1 0.0002
658 TOOTH INFECTION 2 0.0002
659 STAPHYLOCOCCAL INFECTION 5 0.0002
660 SINUS DISORDER 3 0.0002
661 CORONAVIRUS INFECTION 1 0.0002
662 DYSMENORRHOEA 2 0.0002
663 ADVERSE REACTION 2 0.0002
664 EXPIRED PRODUCT ADMINISTERED 5 0.0002
665 VIRAL INFECTION 5 0.0002
666 SPINAL FRACTURE 3 0.0001
667 INTENTIONAL SELF-INJURY 3 0.0001
668 CONFUSIONAL STATE 24 0.0001
669 PRODUCT STORAGE ERROR 13 0.0001
670 PRODUCT ADMINISTRATION ERROR 3 0.0001
671 SINUS CONGESTION 2 0.0001
672 UVEITIS 2 0.0001
673 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
674 ABNORMAL LOSS OF WEIGHT 1 0.0001
675 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
676 RESPIRATORY ARREST 4 0.0001
677 PAIN 89 0.0001
678 DROOLING 1 0.0001
679 FEELING COLD 4 0.0001
680 COORDINATION ABNORMAL 2 0.0001
681 DERMATITIS 3 0.0001
682 HEART RATE DECREASED 5 0.0001
683 APPLICATION SITE REACTION 1 0.0001
684 MYALGIA 24 0.0001
685 RETCHING 3 0.0001
686 LOSS OF CONSCIOUSNESS 18 0.0001
687 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
688 ASTHENIA 52 0.0001
689 MENTAL DISORDER 6 0.0001
690 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
691 ABDOMINAL PAIN 32 0.0001
692 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
693 GASTROENTERITIS 2 0.0001
694 DYSURIA 5 0.0001
695 BLINDNESS TRANSIENT 1 0.0001
696 CEREBRAL DISORDER 1 0.0001
697 SEPSIS 15 0.0001
698 PULMONARY MASS 2 0.0001
699 GLOSSODYNIA 3 0.0001
700 SNEEZING 3 0.0001
701 BACK PAIN 31 0.0001
702 HYPOAESTHESIA ORAL 2 0.0001
703 DEPRESSED MOOD 7 0.0001
704 AORTIC ANEURYSM 1 0.0001
705 INFECTION 19 0.0001
706 HIP ARTHROPLASTY 2 0.0001
707 BOWEL MOVEMENT IRREGULARITY 1 0.0001
708 SHOCK 3 0.0001
709 DRUG EFFECT DECREASED 7 0.0001
710 OROPHARYNGEAL PAIN 12 0.0001
711 RENAL DISORDER 6 0.0001
712 DELUSION 2 0.0001
713 FLUSHING 13 0.0001
714 HYPERTENSION 27 0.0001
715 FATIGUE 99 0.0001
716 ANAPHYLACTIC REACTION 7 0.0001
717 PRODUCT PRESCRIBING ERROR 3 0.0001
718 HYPERHIDROSIS 16 0.0001
719 LOCALISED INFECTION 3 0.0001
720 HYPERSENSITIVITY 23 0.0001
721 PNEUMONIA 40 0.0001
722 PRESYNCOPE 3 0.0001
723 BACK DISORDER 2 0.0001
724 CEREBRAL INFARCTION 3 0.0001
725 DECUBITUS ULCER 1 0.0001
726 PRODUCT USE ISSUE 23 0.0001
727 ABNORMAL FAECES 1 0.0001
728 MULTIPLE FRACTURES 2 0.0001
729 OSTEOPOROSIS 5 0.0001
730 ABASIA 3 0.0001
731 VISUAL IMPAIRMENT 15 0.0001
732 ANAEMIA 23 0.0001
733 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
734 PNEUMONIA ASPIRATION 3 0.0001
735 SKIN DISORDER 4 0.0001
736 GAIT INABILITY 4 0.0001
737 ATRIAL SEPTAL DEFECT 1 0.0001
738 NASAL CONGESTION 7 0.0001
739 TYPE 2 DIABETES MELLITUS 4 0.0001
740 CARDIOVASCULAR DISORDER 3 0.0001
741 HEMIPARESIS 2 0.0001
742 GASTRIC DISORDER 4 0.0001
743 UNRESPONSIVE TO STIMULI 3 0.0001
744 HYPOACUSIS 5 0.0001
745 SKIN ULCER 3 0.0001
746 DYSPHAGIA 11 0.0001
747 OVERDOSE 25 0.0001
748 CARDIAC MURMUR 1 0.0001
749 DIPLOPIA 3 0.0001
750 WEIGHT DECREASED 32 0.0001
751 RASH MACULAR 4 0.0001
752 ANHEDONIA 3 0.0001
753 BLOOD CALCIUM INCREASED 1 0.0001
754 DRUG ERUPTION 2 0.0001
755 INJECTION SITE BRUISING 9 0.0001
756 RASH 49 0.0001
757 PRODUCT ADHESION ISSUE 4 0.0001
758 THIRST 2 0.0001
759 PRURITUS 43 0.0001
760 THROAT IRRITATION 5 0.0001
761 THERAPY NON-RESPONDER 5 0.0001
762 ANAL INCONTINENCE 1 0.0001
763 HEART RATE INCREASED 11 0.0001
764 VOMITING 52 0.0001
765 OSTEOMYELITIS 2 0.0001
766 PELVIC PAIN 2 0.0001
767 SKIN LESION 3 0.0001
768 INTENTIONAL OVERDOSE 7 0.0001
769 BLOOD GLUCOSE ABNORMAL 2 0.0001
770 INJECTION SITE MASS 4 0.0001
771 PROCEDURAL PAIN 3 0.0001
772 ARTHROPATHY 6 0.0001
773 HAEMOPTYSIS 3 0.0001
774 SWELLING FACE 7 0.0001
775 WOUND 3 0.0001
776 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
777 FOOT FRACTURE 2 0.0001
778 RENAL FAILURE 14 0.0001
779 ANGINA PECTORIS 3 0.0001
780 PULMONARY FIBROSIS 2 0.0001
781 EYE IRRITATION 6 0.0001
782 LOWER LIMB FRACTURE 2 0.0001
783 HERNIA 2 0.0001
784 PLASMA CELL MYELOMA 4 0.0001
785 COELIAC DISEASE 1 0.0001
786 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
787 ACUTE MYOCARDIAL INFARCTION 3 0.0001
788 ABNORMAL BEHAVIOUR 4 0.0001
789 BLOOD PRESSURE ABNORMAL 2 0.0001
790 AGGRESSION 5 0.0001
791 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 18 0.0001
792 BLOOD POTASSIUM DECREASED 3 0.0001
793 BRAIN INJURY 1 0.0001
794 FULL BLOOD COUNT DECREASED 2 0.0001
795 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
796 DRY THROAT 1 0.0001
797 FLUID RETENTION 5 0.0001
798 EPILEPSY 3 0.0001
799 DIARRHOEA 63 0.0001
800 EMOTIONAL DISORDER 3 0.0001
801 ILLNESS 10 0.0001
802 DEATH 83 0.0001
803 NERVOUS SYSTEM DISORDER 3 0.0001
804 MALAISE 42 0.0001
805 MUSCULOSKELETAL PAIN 5 0.0001
806 RENAL IMPAIRMENT 8 0.0001
807 MOUTH ULCERATION 2 0.0001
808 DECREASED APPETITE 22 0.0001
809 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
810 CHILLS 11 0.0001
811 BODY HEIGHT DECREASED 1 0.0001
812 HIP FRACTURE 3 0.0001
813 LIVER FUNCTION TEST INCREASED 2 0.0001
814 HOT FLUSH 7 0.0001
815 RHINORRHOEA 6 0.0001
816 DECREASED ACTIVITY 1 0.0001
817 RASH PRURITIC 5 0.0001
818 NASOPHARYNGITIS 17 0.0001
819 BACK INJURY 1 0.0001
820 CHEST PAIN 17 0.0001
821 DYSPEPSIA 9 0.0001
822 DRUG WITHDRAWAL SYNDROME 8 0.0001
823 DENTAL CARIES 1 0.0001
824 OEDEMA PERIPHERAL 11 0.0001
825 HEPATOTOXICITY 2 0.0001
826 EYE PRURITUS 3 0.0001
827 RASH PAPULAR 2 0.0001
828 ARTHRITIS 7 0.0001
829 ARTHRALGIA 37 0.0001
830 OXYGEN SATURATION DECREASED 5 0.0001
831 BLOOD CALCIUM DECREASED 1 0.0001
832 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
833 CHROMATURIA 2 0.0001
834 HEART RATE IRREGULAR 2 0.0001
835 FLATULENCE 5 0.0001
836 APPLICATION SITE PRURITUS 2 0.0001
837 PALPITATIONS 10 0.0001
838 INJURY 6 0.0001
839 ACUTE KIDNEY INJURY 13 0.0001
840 RASH ERYTHEMATOUS 4 0.0001
841 BLOOD PRESSURE FLUCTUATION 2 0.0001
842 THERAPEUTIC RESPONSE DECREASED 5 0.0001
843 DISCOMFORT 5 0.0001
844 FEELING HOT 5 0.0001
845 CYST 1 0.0001
846 EXPOSURE DURING PREGNANCY 5 0.0001
847 APPLICATION SITE IRRITATION 1 0.0001
848 DRY EYE 4 0.0001
849 HYPOTENSION 16 0.0001
850 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
851 BRAIN OEDEMA 1 0.0001
852 GASTRIC CANCER 2 0.0001
853 PRODUCT COMPLAINT 2 0.0001
854 COUGH 22 0.0001
855 INJECTION SITE SWELLING 6 0.0001
856 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
857 PYREXIA 27 0.0001
858 ABDOMINAL PAIN UPPER 16 0.0001
859 JOINT STIFFNESS 2 0.0001
860 ANKYLOSING SPONDYLITIS 1 0.0001
861 INFUSION RELATED REACTION 5 0.0001
862 BLINDNESS 3 0.0001
863 PALLOR 2 0.0001
864 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
865 CARDIAC ARREST 6 0.0001
866 POLLAKIURIA 3 0.0001
867 INFLUENZA 8 0.0001
868 HOSPITALISATION 11 0.0001
869 SKIN EXFOLIATION 6 0.0001
870 BLINDNESS UNILATERAL 1 0.0001
871 OSTEOARTHRITIS 3 0.0001
872 SYNCOPE 7 0.0001
873 RED BLOOD CELL COUNT DECREASED 2 0.0001
874 SKIN BURNING SENSATION 5 0.0001
875 SEPTIC SHOCK 3 0.0001
876 ERYTHEMA 14 0.0001
877 BLADDER CANCER 4 0.0001
878 LABORATORY TEST ABNORMAL 2 0.0001
879 PSYCHOTIC DISORDER 2 0.0001
880 HAEMORRHAGE 7 0.0001
881 DEVICE ISSUE 6 0.0001
882 BONE LOSS 1 0.0001
883 PRODUCT QUALITY ISSUE 9 0.0001
884 CORONARY ARTERY DISEASE 2 0.0001
885 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
886 DEVICE FAILURE 1 0.0001
887 BLOOD PRESSURE INCREASED 10 0.0001
888 TINNITUS 3 0.0001
889 DEVICE RELATED INFECTION 1 0.0001
890 BASAL CELL CARCINOMA 1 0.0001
891 INTERSTITIAL LUNG DISEASE 3 0.0001
892 ATRIAL FIBRILLATION 6 0.0001
893 DEEP VEIN THROMBOSIS 4 0.0001
894 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
895 ALOPECIA 12 0.0001
896 OSTEONECROSIS 2 0.0001
897 DEHYDRATION 8 0.0001
898 CANDIDA INFECTION 1 0.0001
899 CIRCULATORY COLLAPSE 1 0.0001
900 INJECTION SITE REACTION 4 0.0001
901 MYOCARDIAL INFARCTION 10 0.0001
902 AMENORRHOEA 1 0.0001
903 COVID-19 10 0.0001
904 PANCREATITIS 3 0.0001
905 INJECTION SITE ERYTHEMA 7 0.0001
906 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
907 TREATMENT NONCOMPLIANCE 3 0.0001
908 HAEMATOCHEZIA 3 0.0001
909 EPISTAXIS 4 0.0001
910 BLOOD GLUCOSE INCREASED 10 0.0001
911 INTESTINAL OBSTRUCTION 2 0.0001
912 BLOOD URINE PRESENT 1 0.0001
913 INCORRECT DOSE ADMINISTERED 12 0.0001
914 DRY SKIN 7 0.0001
915 HERPES ZOSTER 3 0.0001
916 DRUG PRESCRIBING ERROR 1 0.0001
917 EAR PAIN 1 0.0001
918 INJECTION SITE HAEMORRHAGE 4 0.0001
919 CARDIAC FAILURE 4 0.0000
920 JOINT SWELLING 6 0.0000
921 STOMATITIS 3 0.0000
922 PSORIATIC ARTHROPATHY 2 0.0000
923 DEVICE BREAKAGE 2 0.0000
924 NEUTROPHIL COUNT DECREASED 2 0.0000
925 BODY TEMPERATURE INCREASED 1 0.0000
926 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
927 HAEMOGLOBIN DECREASED 5 0.0000
928 INFLUENZA LIKE ILLNESS 4 0.0000
929 EATING DISORDER 1 0.0000
930 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
931 DEVICE LEAKAGE 2 0.0000
932 DEVICE DISLOCATION 2 0.0000
933 PSORIASIS 6 0.0000
934 APPLICATION SITE PAIN 1 0.0000
935 ANGIOEDEMA 2 0.0000
936 INJECTION SITE PRURITUS 3 0.0000
937 SKIN IRRITATION 2 0.0000
938 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
939 INJECTION SITE PAIN 13 0.0000
940 ARRHYTHMIA 2 0.0000
941 OCULAR HYPERAEMIA 2 0.0000
942 DISEASE RECURRENCE 2 0.0000
943 THERAPY INTERRUPTED 3 0.0000
944 BLOOD GLUCOSE DECREASED 2 0.0000
945 EMOTIONAL DISTRESS 5 0.0000
946 HYPOGLYCAEMIA 2 0.0000
947 RESPIRATORY FAILURE 3 0.0000
948 UNDERDOSE 3 0.0000
949 DYSGEUSIA 3 0.0000
950 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
951 ANAPHYLACTIC SHOCK 1 0.0000
952 INFLAMMATION 2 0.0000
953 NO ADVERSE EVENT 7 0.0000
954 APPLICATION SITE ERYTHEMA 1 0.0000
955 DERMATITIS ATOPIC 2 0.0000
956 BRADYCARDIA 2 0.0000
957 EAR INFECTION 1 0.0000
958 BREAST CANCER FEMALE 1 0.0000
959 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
960 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
961 CEREBROVASCULAR ACCIDENT 6 0.0000
962 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
963 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
964 PLEURAL EFFUSION 2 0.0000
965 BREAST CANCER 3 0.0000
966 CARDIAC DISORDER 3 0.0000
967 BONE DENSITY DECREASED 1 0.0000
968 DRUG DOSE OMISSION 5 0.0000
969 NEOPLASM MALIGNANT 2 0.0000
970 NEUTROPENIA 4 0.0000
971 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
972 DEVICE MALFUNCTION 2 0.0000
973 PLATELET COUNT DECREASED 3 0.0000
974 CEREBRAL HAEMORRHAGE 1 0.0000
975 DRUG EFFECT INCOMPLETE 1 0.0000
976 RHEUMATOID ARTHRITIS 3 0.0000
977 COLITIS 1 0.0000
978 ABORTION SPONTANEOUS 1 0.0000
979 PROSTATE CANCER 2 0.0000
980 DRUG DEPENDENCE 3 0.0000
981 DEPENDENCE 1 0.0000
982 THROMBOCYTOPENIA 2 0.0000
983 CONVULSION 1 0.0000
984 BONE PAIN 1 0.0000
985 DEVICE EXPULSION 1 0.0000
986 BLOOD CREATININE INCREASED 1 0.0000
987 DEVICE DIFFICULT TO USE 1 0.0000
988 ACNE 1 0.0000
989 DISEASE PROGRESSION 1 0.0000